Masimo Corporation (LON:0JZ2)

London flag London · Delayed Price · Currency is GBP · Price in USD
153.06
-1.04 (-0.67%)
At close: Apr 17, 2025
12.78%
Market Cap 6.44B
Revenue (ttm) 1.66B
Net Income (ttm) -242.17M
Shares Out n/a
EPS (ttm) -4.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6
Average Volume 135
Open 152.10
Previous Close 154.10
Day's Range 151.83 - 153.06
52-Week Range 75.35 - 197.07
Beta 1.28
RSI 52.98
Earnings Date May 8, 2025

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1989
Employees 3,600
Stock Exchange London Stock Exchange
Ticker Symbol 0JZ2
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 at 2:15...

22 days ago - Business Wire

$1000 Invested In Masimo 15 Years Ago Would Be Worth This Much Today

Masimo (NASDAQ: MASI) has outperformed the market over the past 15 years by 2.1% on an annualized basis producing an average annual return of 13.19%. Currently, Masimo has a market capitalization of ...

5 weeks ago - Benzinga

Shareholder Alert: Johnson Fistel, LLP Investigates Domino's Pizza, Masimo, Acadia Healthcare, and American Express—Long-Term Investors are Encouraged to Contact the Firm

SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a shareholder rights law firm, is investigating potential violations of federal and state laws by officers and directors of Domino's ...

7 weeks ago - Benzinga

Masimo Corp (MASI) to Present at 46th Annual Raymond James Institutional Investor Conference

Masimo Corp (MASI) to Present at 46th Annual Raymond James Institutional Investor Conference

7 weeks ago - GuruFocus

Masimo to Present in the 46th Annual Raymond James Institutional Investor Conference

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025...

7 weeks ago - Business Wire

Masimo (MASI) Stock Surges on Strong Q4 Results

Masimo (MASI) Stock Surges on Strong Q4 Results

2 months ago - GuruFocus

Masimo Corp (MASI) Shares Up 10.45% on Feb 26

Masimo Corp (MASI) Shares Up 10.45% on Feb 26

2 months ago - GuruFocus

Masimo Makes A Bullish Post-Earnings Move. Why One Analyst Is Cautious.

Masimo stock surged Wednesday on its upbeat earnings and 2025 outlook, though one analyst cautioned cost reductions could squeeze profits.

2 months ago - Investor's Business Daily

Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript

Masimo Corporation (NASDAQ:MASI) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ETCompany ParticipantsEli Kammerman - Vice President, Business...

2 months ago - Seeking Alpha

Masimo Tops EPS, Revenue Expectations

Masimo impressed with a robust earnings report driven by its healthcare segment, despite challenges from non-healthcare operations.

2 months ago - The Motley Fool

Masimo Corp Q4 2024 Earnings: EPS of $1.80 Beats Estimate, Revenue Surpasses Forecast at $601 ...

Masimo Corp Q4 2024 Earnings: EPS of $1.80 Beats Estimate, Revenue Surpasses Forecast at $601 Million

2 months ago - GuruFocus

Masimo Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Updated Full-Year 2025 Guidance

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 28, 2024 and provided updated estimates for its full-ye...

2 months ago - Business Wire

Masimo Corporation Q4 2024 Earnings Preview

2 months ago - Seeking Alpha

Price Over Earnings Overview: Masimo

In the current market session, Masimo Inc. (NASDAQ: MASI) stock price is at $179.97, after a 0.22% drop. However, over the past month, the company's stock increased by 5.38% , and in the past year, b...

2 months ago - Benzinga

FMR LLC Increases Stake in Masimo Corp: A Strategic Move in Healthcare Technology

FMR LLC Increases Stake in Masimo Corp: A Strategic Move in Healthcare Technology

2 months ago - GuruFocus

(MASI) - Analyzing Masimo's Short Interest

Masimo's (NYSE: MASI) short percent of float has risen 3.23% since its last report. The company recently reported that it has 2.91 million shares sold short , which is 9.91% of all regular shares tha...

2 months ago - Benzinga

BlackRock, Inc. Reduces Stake in Masimo Corp: A Detailed Analysis

BlackRock, Inc. Reduces Stake in Masimo Corp: A Detailed Analysis

2 months ago - GuruFocus

Here's How Much $1000 Invested In Masimo 15 Years Ago Would Be Worth Today

Masimo (NASDAQ: MASI) has outperformed the market over the past 15 years by 1.2% on an annualized basis producing an average annual return of 13.4%. Currently, Masimo has a market capitalization of $...

2 months ago - Benzinga

Masimo Taps Katie Szyman as Permanent CEO

Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co.

3 months ago - WSJ

Masimo names Becton Dickinson's Katie Szyman CEO

Masimo said on Tuesday it has named Becton Dickinson executive Katie Szyman as chief executive officer after a bitter proxy battle with activist hedge fund Politan Capital Management led to the ouster...

3 months ago - Reuters

Masimo appoints Katie Szyman as CEO

3 months ago - Seeking Alpha

Masimo Announces Leadership Transition

IRVINE, Calif.--(BUSINESS WIRE)--Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Chief ...

3 months ago - Business Wire

Masimo expects Q4 revenue of $601 million

3 months ago - Seeking Alpha